Is Cronos Group Inc. (NASDAQ:CRON) a buy in 2026?
Hold. Cronos Group Inc. is a wait-and-watch at today's price, not a fresh buy.
Cannabis survivor with a billion in cash and no debt, but the catalyst that justifies a re-rating still hasn't arrived.
Where CRON is headed
Cronos in mid-2028 looks less like a cannabis play and more like a cash-rich specialty wellness company waiting for US federal reform to finally let it spend. Revenue should clear $200m on the back of Israeli medical demand and Spinach gaining share in the Canadian flower category, where the brand has crept into the top three across Ontario and BC. Gross margin trajectory matters more than the headline. The Cronos GrowCo facility in Kingsville is finally running closer to design throughput, and the company is exporting Canadian-grown bulk into Germany and Australia where medical pricing is roughly 4x domestic. That mix shift, if it holds, takes gross margin from 40% toward 50% and lets operating losses narrow to break-even by late 2027.
Read the full Compass Direction on CRON
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $2.79).
See the full CRON analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Cronos Group Inc. (NASDAQ:CRON) a buy in 2026?
Hold. Cronos Group Inc. is a wait-and-watch at today's price, not a fresh buy. Cannabis survivor with a billion in cash and no debt, but the catalyst that justifies a re-rating still hasn't arrived.
What is CRON's Compass Score?
Cronos Group Inc. scores 82/100 on Alexandria's Compass, placing it in the "True North" tier. Scores blend eight factors and update weekly.
What is the price target for CRON?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the CRON page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.